Literature DB >> 18039320

Tfm-AR modulates the effects of ApoE4 on cognition.

Angela Rizk-Jackson1, Jennifer Robertson, Jacob Raber.   

Abstract

Female mice are more susceptible to apolipoprotein E (apoE4)-induced cognitive deficits than male mice. These deficits can be antagonized by stimulating androgen receptors (ARs). To determine the role of AR in the cognitive effects of apoE4, we backcrossed mutant mice with a naturally occurring defect in the AR [testicular feminization mutant (tfm)] onto the Apoe-/- background to eliminate mouse apoE gene resulting in non-functional AR, and crossed the tfm/Apoe-/- female mice with apoE4 transgenic male mice. We behaviorally compared Apoe-/-, apoE4, tfm, and tfm/apoE4 male mice. Apoe-/-, apoE4, and tfm mice showed hippocampus-dependent novel location recognition but tfm/apoE4 mice did not. In contrast, all groups showed hippocampus-independent novel object recognition. Hippocampus-dependent learning and memory were also assessed in the water maze. In the water maze probe trial following the second day of hidden platform training, Apoe-/- and apoE4 mice showed spatial memory retention, but tfm and tfm/ApoE4 mice did not. In the water maze, probe trial following the third day of hidden platform training, Apoe-/-, apoE4, and tfm/Apoe-/- mice showed spatial memory retention, but tfm mice did not. These data support an important role for AR in protecting against the detrimental effects of apoE4 on hippocampus-dependent learning and memory.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039320     DOI: 10.1111/j.1471-4159.2007.05092.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women.

Authors:  Diana Morales; Summer F Acevedo; Richard L Skolasky; Rosa Hechavarria; Sharon Santiago; Tania De La Torre; Elizabeth Maldonado; Valerie Wojna
Journal:  J Neurovirol       Date:  2012-09-13       Impact factor: 2.643

2.  Interaction of APOE genotype and testosterone on episodic memory in middle-aged men.

Authors:  Matthew S Panizzon; Richard Hauger; Hong Xian; Eero Vuoksimaa; Kelly M Spoon; Sally P Mendoza; Kristen C Jacobson; Terrie Vasilopoulos; Brinda K Rana; Ruth McKenzie; Jeanne M McCaffery; Michael J Lyons; William S Kremen; Carol E Franz
Journal:  Neurobiol Aging       Date:  2013-12-27       Impact factor: 4.673

3.  Testosterone modifies the effect of APOE genotype on hippocampal volume in middle-aged men.

Authors:  M S Panizzon; R Hauger; A M Dale; L J Eaves; L T Eyler; B Fischl; C Fennema-Notestine; C E Franz; M D Grant; A J Jak; K C Jacobson; M J Lyons; S P Mendoza; M C Neale; E C Prom-Wormley; L J Seidman; M T Tsuang; H Xian; W S Kremen
Journal:  Neurology       Date:  2010-09-07       Impact factor: 9.910

Review 4.  Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Curr Diab Rep       Date:  2014-04       Impact factor: 4.810

Review 5.  AR, apoE, and cognitive function.

Authors:  Jacob Raber
Journal:  Horm Behav       Date:  2008-02-26       Impact factor: 3.587

6.  Neural Androgen Receptors Modulate Gene Expression and Social Recognition But Not Social Investigation.

Authors:  Sara A Karlsson; Erik Studer; Petronella Kettunen; Lars Westberg
Journal:  Front Behav Neurosci       Date:  2016-03-16       Impact factor: 3.558

7.  46,XY DSD with Female or Ambiguous External Genitalia at Birth due to Androgen Insensitivity Syndrome, 5alpha-Reductase-2 Deficiency, or 17beta-Hydroxysteroid Dehydrogenase Deficiency: A Review of Quality of Life Outcomes.

Authors:  Amy B Wisniewski; Tom Mazur
Journal:  Int J Pediatr Endocrinol       Date:  2009-09-10

8.  Postmenopausal cognitive changes and androgen levels in the context of apolipoprotein E polymorphism.

Authors:  Iwona Bojar; Jarosław Pinkas; Mariusz Gujski; Alfred Owoc; Dorota Raczkiewicz; Kasia Gustaw-Rothenberg
Journal:  Arch Med Sci       Date:  2016-10-10       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.